Could serum pentraxin 3 levels and IgM deposition in skin biopsies predict subsequent renal involvement in children with Henoch–Schönlein purpura?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00467-014-3026-xPMID 25543194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The correlation between cutaneous IgM deposition and renal involvement in adult patients with Henoch-Schönlein purpura

  2014cited by this paper
• Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children

  2014cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital.

  2012cited by this paper
• The Evaluation of Immun Deposits on Skin of the Patients with Henoch-Schonlein Purpura

  2012cited by this paper
• M-Ficolin Interacts with the Long Pentraxin PTX3: A Novel Case of Cross-Talk between Soluble Pattern-Recognition Molecules

  2011cited by this paper
• IgM in lesional skin is indicative of renal involvement in adults with Henoch-Schönlein purpura but not children.

  2011cited by this paper
• IgM in lesional skin of adults with Henoch-Schönlein purpura is an indication of renal involvement.

  2010cited by this paper
• EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria

  2010cited by this paper
• Heterocomplexes of Mannose-binding Lectin and the Pentraxins PTX3 or Serum Amyloid P Component Trigger Cross-activation of the Complement System*

  2010cited by this paper
• The long pentraxin 3 and its role in autoimmunity.

  2009cited by this paper
• Henoch‐Schönlein purpura nephritis in children: risk factors, prevention and treatment

  2009cited by this paper
• Binding of the Long Pentraxin PTX3 to Factor H: Interacting Domains and Function in the Regulation of Complement Activation1

  2008cited by this paper
• Pentraxins in Innate Immunity: From C-Reactive Protein to the Long Pentraxin PTX3

  2007cited by this paper
• Clinical update: Henoch-Schönlein purpura.

  2007cited by this paper
• Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis.

  2006cited by this paper
• Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.

  2005cited by this paper
• Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis

  2004cited by this paper
• Biochemical and functional characterization of the interaction between pentraxin 3 and C1q

  2003cited by this paper
• The Long Pentraxin Ptx3 Is Synthesized in IgA Glomerulonephritis and Activates Mesangial Cells 1

  2003influential reference
• PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.

  2001cited by this paper
• What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

  2001cited by this paper
• Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors.

  1998cited by this paper
• Prognosis of Henoch-Schönlein nephritis in children.

  1977cited by this paper
• Schönlein-Henoch nephritis.

  1972cited by this paper

• Biomarkers to predict kidney outcomes in children with IgA vasculitis.

  2025cites this paper
• IgA Vasculitis in adults: Importance of recognising diverse cutaneous and systemic manifestations and associations.

  2025cites this paper
• The pentraxin family in autoimmune disease.

  2023cites this paper
• Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role.

  2022cites this paper
• Ampicillin‐sulbactam monotherapy in infants with febrile urinary tract infections

  2020cites this paper
• Direct Immunofluorescence Results of the Skin Biopsy and Frequency of Systemic Involvement in Children with Henoch-Schonlein Purpura

  2019cites this paper
• Urinary excretion of pentraxin-3 correlates with the presence of renal scar following acute pyelonephritis in children

  2019cites this paper
• Düşük Kompleman Düzeyi Olan Henoch Schönlein Purpuralı Çocuk Hastaların Değerlendirilmesi

  2018cites this paper
• Biomarkers of IgA vasculitis nephritis in children

  2017cites this paper
• Cerebral Vasculitis in Henoch-Schönlein Purpura: A Case Report.

  2017cites this paper
• [Research advances in immunological pathogenesis of immunoglobulin A vasculitis].

  2017influential citation
• Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications.

  2016cites this paper
• An Efficient and Comprehensive Strategy for Genetic Diagnostics of Polycystic Kidney Disease

  2015cites this paper
• Review IgA vasculitis with nephritis: an overview of the pathogenesis and clinical characteristics

  year unknowncites this paper